Kwality Pharmaceuticals Ltd Performance
Day's Low
₹866.95Day's Price Range₹900.6552 Week's Low
52 Week's High
₹40552-Week Price Range₹1,069.95
| Returns % | |
| 1 Month Return | -2.5 % |
| 3 Month Return | + 4.83 % |
| 1 Year Return | + 86.64 % |
| Market Stats | |
| Previous Close | ₹857.80 |
| Open | ₹900.65 |
| Volume | 33.13K |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹890.07Cr |
Kwality Pharmaceuticals Ltd Key Statistics
| P/E Ratio | 31.01 |
| PEG Ratio | 1.83 |
| Market Cap | ₹890.07 Cr |
| P/B Ratio | 1.89 |
| EPS | 22.76 |
| Dividend Yield | 0 |
| Sector | Pharmaceuticals |
| ROE | 13.74 |
Kwality Pharmaceuticals Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹890.07 Cr | 539.74% | 0.65 | ₹23 Cr | ₹307 Cr | |
| BUY | ₹14,495.06 Cr | 65.42% | 0.63 | ₹405 Cr | ₹4,506 Cr | |
| NA | ₹493.21 Cr | 18.44% | 0.00 | NA | NA | |
| NA | ₹15,135.40 Cr | -0.97% | 0.73 | ₹82 Cr | ₹1,465 Cr | |
| NA | ₹5,015.00 Cr | 63.63% | 0.52 | -₹71 Cr | ₹1,704 Cr |
About Kwality Pharmaceuticals Ltd
Share Price: ₹900.65 per share as on 21 Jan, 2025 01:59 PM
Market Capitalisation: ₹890.07Cr as of today
Revenue: ₹90.03Cr as on September 2024 (Q3 24)
Net Profit: ₹8.46Cr as on September 2024 (Q3 24)
| Organisation | Kwality Pharmaceuticals Ltd |
| Headquarters | |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Key events for Kwality Pharmaceuticals Ltd
Kwality Pharmaceuticals Secures Approval for Erythropoietin - 02 Jan, 2025
Kwality Pharmaceuticals has received approval from RCGM to begin pre-clinical toxicity studies for its Erythropoietin product, marking a significant step in expanding its biologics portfolio. The company reported a 30% increase in net sales and a 36% rise in net profits for Q2 FY25.Kwality Pharma Secures SAHPRA Approval for Tamoxifen - 24 Dec, 2024
Kwality Pharmaceuticals gained 1.95% after receiving SAHPRA approval for its Tamoxifen Tablet, enhancing its oncology product portfolio and market presence. The company reported a 35.7% increase in net profit for Q2 FY25.
Insights on Kwality Pharmaceuticals Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 2 quarters, 80.36 Cr → 90.26 Cr (in ₹), with an average increase of 11.0% per quarter
- POSITIVE IMPACT
Best in 1 Year
In the last 1 year, Kwality Pharma has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
Price Rise
In the last 7 days, Kwality Pharma stock has moved up by 5.8%
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 3 quarters, 4.36 Cr → 8.47 Cr (in ₹), with an average increase of 24.6% per quarter
NO EFFECTAgainst Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 103.2% return, outperforming this stock by 73.4%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 54.83% of holdings in Sep 2024 quarter
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 45.17% to 45.15% in Sep 2024 quarter
Kwality Pharmaceuticals Ltd Financials
Kwality Pharmaceuticals Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 54.83% | 0.00 | |
| Foreign Institutions | 0% | 0.00 | |
| Mutual Funds | 0% | 0.00 | |
| Retail Investors | 45.15% | ||
| Others | 0.02% | 0.00 |
Kwality Pharmaceuticals Ltd Key Indicators
Kwality Pharmaceuticals Ltd Valuation
Kwality Pharmaceuticals Ltd in the last 5 years
Lowest (2.58x)
June 29, 2022
Today (31.01x)
January 20, 2025
Industry (55.28x)
January 20, 2025
Highest (46.50x)
February 21, 2024
Kwality Pharmaceuticals Ltd Earnings and Dividends
Kwality Pharmaceuticals Ltd Earnings Results
Kwality Pharmaceuticals Ltd’s net profit jumped 35.74% since last year same period to ₹8.47Cr in the Q2 2024-2025. On a quarterly growth basis, Kwality Pharmaceuticals Ltd has generated 1.32% jump in its net profits since last 3-months.
Read More about Earnings ResultsKwality Pharmaceuticals Ltd Dividends December,2016
In the quarter ending September 2016, Kwality Pharmaceuticals Ltd has declared dividend of ₹0.60 - translating a dividend yield of 0.07%.
Read More about Dividends
Kwality Pharmaceuticals Ltd Technicals Summary
Bearish
Neutral
Bullish
Kwality Pharmaceuticals Ltd is currently in a Bullish trading position according to technical analysis indicators.
FAQs on Kwality Pharmaceuticals Ltd
Kwality Pharmaceuticals Ltd share price today stands at ₹900.65, Open. ₹900.65 ; Previous Close. ₹857.8 ; High. ₹900.65 ; Low. ₹866.95 ; 52 Week High. ₹1069.95 ; 52 Week Low: ₹405.
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Kwality Pharmaceuticals Ltd shares.
Kwality Pharmaceuticals Ltd is not listed on NSE
Kwality Pharmaceuticals Ltd is listed on BSE
- Today’s highest price of Kwality Pharmaceuticals Ltd is ₹900.65.
- Today’s lowest price of Kwality Pharmaceuticals Ltd is ₹866.95.
PE Ratio of Kwality Pharmaceuticals Ltd is 31.01
PE ratio = Kwality Pharmaceuticals Ltd Market price per share / Kwality Pharmaceuticals Ltd Earnings per share
Today’s traded volume of Kwality Pharmaceuticals Ltd(539997) is 33.13K.
Today’s market capitalisation of Kwality Pharmaceuticals Ltd(539997) is ₹890.07Cr.
| Kwality Pharmaceuticals Ltd(539997 | Price |
|---|---|
52 Week High | ₹1069.95 |
52 Week Low | ₹405 |
Kwality Pharmaceuticals Ltd(539997) share price is ₹900.65. It is down -15.82% from its 52 Week High price of ₹1069.95
Kwality Pharmaceuticals Ltd(539997) share price is ₹900.65. It is up 122.38% from its 52 Week Low price of ₹405
| Kwality Pharmaceuticals Ltd(539997 | Returns |
|---|---|
1 Day Returns | 42.85% |
1 Month Returns | -2.5% |
3 Month Returns | 4.83% |
1 Year Returns | 86.64% |